vs

Side-by-side financial comparison of FOX FACTORY HOLDING CORP (FOXF) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $361.1M, roughly 1.4× FOX FACTORY HOLDING CORP). On growth, FOX FACTORY HOLDING CORP posted the faster year-over-year revenue change (2.3% vs -1.7%). Over the past eight quarters, FOX FACTORY HOLDING CORP's revenue compounded faster (4.1% CAGR vs -0.1%).

Fox Factory Holding Corp. is an American company best known for their Fox Racing Shox brand of off-road racing suspension components.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

FOXF vs MD — Head-to-Head

Bigger by revenue
MD
MD
1.4× larger
MD
$493.8M
$361.1M
FOXF
Growing faster (revenue YoY)
FOXF
FOXF
+4.0% gap
FOXF
2.3%
-1.7%
MD
Faster 2-yr revenue CAGR
FOXF
FOXF
Annualised
FOXF
4.1%
-0.1%
MD

Income Statement — Q4 FY2027 vs Q4 FY2025

Metric
FOXF
FOXF
MD
MD
Revenue
$361.1M
$493.8M
Net Profit
$33.7M
Gross Margin
28.3%
Operating Margin
-13.0%
9.9%
Net Margin
6.8%
Revenue YoY
2.3%
-1.7%
Net Profit YoY
10.5%
EPS (diluted)
$-6.86
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FOXF
FOXF
MD
MD
Q4 26
$361.1M
Q4 25
$376.4M
$493.8M
Q3 25
$374.9M
$492.9M
Q2 25
$355.0M
$468.8M
Q1 25
$352.8M
$458.4M
Q4 24
$502.4M
Q3 24
$359.1M
$511.2M
Q2 24
$348.5M
$504.3M
Net Profit
FOXF
FOXF
MD
MD
Q4 26
Q4 25
$-634.0K
$33.7M
Q3 25
$2.7M
$71.7M
Q2 25
$-259.7M
$39.3M
Q1 25
$-141.0K
$20.7M
Q4 24
$30.5M
Q3 24
$4.8M
$19.4M
Q2 24
$5.4M
$-153.0M
Gross Margin
FOXF
FOXF
MD
MD
Q4 26
28.3%
Q4 25
30.4%
Q3 25
31.2%
Q2 25
30.9%
Q1 25
28.9%
Q4 24
Q3 24
29.9%
Q2 24
31.8%
Operating Margin
FOXF
FOXF
MD
MD
Q4 26
-13.0%
Q4 25
4.0%
9.9%
Q3 25
4.9%
13.8%
Q2 25
-70.6%
12.8%
Q1 25
3.2%
7.0%
Q4 24
7.8%
Q3 24
5.2%
6.6%
Q2 24
5.3%
-31.3%
Net Margin
FOXF
FOXF
MD
MD
Q4 26
Q4 25
-0.2%
6.8%
Q3 25
0.7%
14.5%
Q2 25
-73.1%
8.4%
Q1 25
-0.0%
4.5%
Q4 24
6.1%
Q3 24
1.3%
3.8%
Q2 24
1.6%
-30.3%
EPS (diluted)
FOXF
FOXF
MD
MD
Q4 26
$-6.86
Q4 25
$-0.02
$0.40
Q3 25
$0.07
$0.84
Q2 25
$-6.23
$0.46
Q1 25
$0.00
$0.24
Q4 24
$0.37
Q3 24
$0.11
$0.23
Q2 24
$0.13
$-1.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FOXF
FOXF
MD
MD
Cash + ST InvestmentsLiquidity on hand
$58.0M
$375.2M
Total DebtLower is stronger
$26.9M
$570.5M
Stockholders' EquityBook value
$670.2M
$865.9M
Total Assets
$1.7B
$2.2B
Debt / EquityLower = less leverage
0.04×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FOXF
FOXF
MD
MD
Q4 26
$58.0M
Q4 25
$375.2M
Q3 25
$340.1M
Q2 25
$224.7M
Q1 25
$71.7M
$99.0M
Q4 24
$229.9M
Q3 24
$103.8M
Q2 24
$19.4M
Total Debt
FOXF
FOXF
MD
MD
Q4 26
$26.9M
Q4 25
$536.7M
$570.5M
Q3 25
$541.8M
$577.2M
Q2 25
$546.9M
$583.9M
Q1 25
$552.1M
$590.5M
Q4 24
$597.1M
Q3 24
$558.4M
Q2 24
$564.1M
Stockholders' Equity
FOXF
FOXF
MD
MD
Q4 26
$670.2M
Q4 25
$956.0M
$865.9M
Q3 25
$958.7M
$890.7M
Q2 25
$939.9M
$833.8M
Q1 25
$1.2B
$789.2M
Q4 24
$764.9M
Q3 24
$1.2B
$732.5M
Q2 24
$1.2B
$706.5M
Total Assets
FOXF
FOXF
MD
MD
Q4 26
$1.7B
Q4 25
$2.0B
$2.2B
Q3 25
$2.0B
$2.2B
Q2 25
$1.9B
$2.1B
Q1 25
$2.2B
$2.0B
Q4 24
$2.2B
Q3 24
$2.3B
$2.1B
Q2 24
$2.3B
$2.0B
Debt / Equity
FOXF
FOXF
MD
MD
Q4 26
0.04×
Q4 25
0.56×
0.66×
Q3 25
0.57×
0.65×
Q2 25
0.58×
0.70×
Q1 25
0.46×
0.75×
Q4 24
0.78×
Q3 24
0.47×
Q2 24
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FOXF
FOXF
MD
MD
Operating Cash FlowLast quarter
$60.9M
$114.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FOXF
FOXF
MD
MD
Q4 26
$60.9M
Q4 25
$5.3M
$114.1M
Q3 25
$36.8M
$137.3M
Q2 25
$680.0K
$137.2M
Q1 25
$81.7M
$-117.5M
Q4 24
$133.0M
Q3 24
$14.1M
$91.8M
Q2 24
$26.7M
$107.0M
Free Cash Flow
FOXF
FOXF
MD
MD
Q4 26
Q4 25
$-2.5M
Q3 25
$24.6M
Q2 25
$-6.5M
Q1 25
$69.8M
Q4 24
Q3 24
$3.2M
Q2 24
$15.4M
FCF Margin
FOXF
FOXF
MD
MD
Q4 26
Q4 25
-0.7%
Q3 25
6.6%
Q2 25
-1.8%
Q1 25
19.8%
Q4 24
Q3 24
0.9%
Q2 24
4.4%
Capex Intensity
FOXF
FOXF
MD
MD
Q4 26
Q4 25
2.1%
Q3 25
3.3%
Q2 25
2.0%
Q1 25
3.4%
Q4 24
Q3 24
3.0%
Q2 24
3.2%
Cash Conversion
FOXF
FOXF
MD
MD
Q4 26
Q4 25
3.39×
Q3 25
13.41×
1.91×
Q2 25
3.49×
Q1 25
-5.66×
Q4 24
4.36×
Q3 24
2.94×
4.72×
Q2 24
4.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FOXF
FOXF

Aftermarket Applications Group$126.2M35%
Specialty Sports Group$118.2M33%
Powered Vehicles Group$116.7M32%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons